Table: Kissei Pharm -2017/18 group results

Kissei Pharmaceutical

08/05/2018 07:00

May 8 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           74.01           71.71          71.70        35.70    
               (+3.2 pct)      (+0.6 pct)     (-3.1 pct)    (-2.4 pct) 
  Operating        9.89            8.49           7.90         3.50    
               (+16.4 pct)     (-17.4 pct)    (-20.1 pct)  (-15.0 pct) 
  Recurring       11.41            9.64           8.90         4.00    
               (+18.4 pct)     (-15.1 pct)    (-22.0 pct)  (-22.7 pct) 
  Net
  Net              9.05            7.73           6.60         3.00    
               (+17.1 pct)     (-5.4 pct)     (-27.0 pct)  (-29.9 pct) 
  EPS          188.26 yen      158.74 yen     141.28 yen    64.22 yen  
  Ann Div       48.00 yen       46.00 yen      50.00 yen               
  -Q2 Div       24.00 yen       23.00 yen      25.00 yen               
  -Q4 Div       24.00 yen       23.00 yen      25.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T